• OPEN AN ACCOUNT
Indian Indices
Sensex
74,314.59 -21.86
( -0.03%)
Global Indices
Nasdaq
51,493.09 -621.02
(-1.19%)
Dow Jones
7,573.47 -33.26
(-0.44%)
Hang Seng
63,960.24 37.24
(0.06%)
Nikkei 225
10,816.25 127.78
(1.20%)
Forex
USD-INR
95.42 0.14
(0.14%)
EUR-INR
110.10 0.01
(0.01%)
GBP-INR
128.62 0.03
(0.02%)
JPY-INR
0.62 0.00
(-0.26%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
66.2311355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
57.4
4219.39
EPS(TTM)
Face Value()
Div & Yield %
7.33
1
0.02
 

Gokaldas Exports consolidated net profit declines 31.97% in the March 2026 quarter
May 23,2026
Net profit of Gokaldas Exports declined 31.97% to Rs 35.96 crore in the quarter ended March 2026 as against Rs 52.86 crore during the previous quarter ended March 2025. Sales rose 5.27% to Rs 1068.85 crore in the quarter ended March 2026 as against Rs 1015.34 crore during the previous quarter ended March 2025.

For the full year,net profit declined 36.84% to Rs 100.13 crore in the year ended March 2026 as against Rs 158.54 crore during the previous year ended March 2025. Sales rose 3.19% to Rs 3987.64 crore in the year ended March 2026 as against Rs 3864.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1068.851015.34 5 3987.643864.24 3
OPM %10.9012.07 -8.949.60 -
PBDT108.60120.57 -10 338.52346.48 -2
PBT69.9679.05 -11 171.62218.07 -21
NP35.9652.86 -32 100.13158.54 -37